← Eichor
Condition: Breast Biopsy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Breast Biopsy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
Phase N/A · 1 location(s) · Julia Foldi · NCT06666439A Multicenter Cancer Biospecimen Collection Study
Phase N/A · 1 location(s) · Cofactor Genomics, Inc. · NCT04510129Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast Cancer
NA · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT07579286cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Phase N/A · 17 location(s) · Adela, Inc · NCT05366881Feasibility of Serial Multisite Image-guided Biopsy to Study Breast Cancer Evolution
Phase N/A · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT07084571Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)
NA · 1 location(s) · Seoul National University Hospital · NCT05505357Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
Phase 3 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT03351348ERAS Protocols in Breast Conserving Surgery
NA · 1 location(s) · University of Nebraska · NCT06938581Application of EndoScell Intraoperative Cellular Probing Technology for Early-Stage Breast Cancer
NA · 1 location(s) · Fudan University · NCT06911528Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metas
Phase N/A · 1 location(s) · European Institute of Oncology · NCT06762483Core Biopsies for Establishing a Breast Tumor Tissue Repository
Phase N/A · 1 location(s) · University of Southern California · NCT02250352Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients Wi
Phase N/A · 6 location(s) · AstraZeneca · NCT06417801Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT07524114Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Syste
NA · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT04293796Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy fo
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07270679Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
Phase N/A · 3 location(s) · Gene Solutions · NCT06087120CfDNA in Hereditary And High-risk Malignancies 2
Phase N/A · 8 location(s) · University Health Network, Toronto · NCT06726642Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammat
Phase N/A · 10 location(s) · M.D. Anderson Cancer Center · NCT00477100Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergo
NA · 54 location(s) · University Hospital, Basel, Switzerland · NCT07140172Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer
Phase N/A · 1 location(s) · Omphis Foundation · NCT06378944Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients
Phase N/A · 1 location(s) · Sunnybrook Health Sciences Centre · NCT04608357Sentinel lympH Node Biopsy With Indocyanine Green in Breast Cancer After NEoadjuvant Chemotherapy (SHINE)
NA · 1 location(s) · University Health Network, Toronto · NCT06085274Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer
NA · 7 location(s) · Isabelle Henskens · NCT07146295Implementation of Solid Digital PCR to Support Gold-standard Methods for Evaluation of HER2 Amplification Status: Focus
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06813456Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Canc
Phase N/A · 1 location(s) · SOLTI Breast Cancer Research Group · NCT06991946CtDNA Based MRD Testing for NAC Monitoring in TNBC
Phase N/A · 14 location(s) · Personalis Inc. · NCT06230185AXillary Surgery After NeoAdjuvant Treatment
Phase N/A · 1 location(s) · European Breast Cancer Research Association of Surgical Tria · NCT04373655Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)
NA · 2 location(s) · Isabelle Henskens · NCT07362485Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology an
Phase N/A · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05561842SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Phase N/A · 1 location(s) · Guardant Health, Inc. · NCT05935384
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.